Highland Capital Management (Tennessee)’s Avadel Pharmaceuticals AVDL Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,861	Closed	-$213K	–	422
2025 Q4	$213K	Buy	+9,861	New	+$191K	0.01%	388

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Highland Capital Management (Tennessee)'s AVDL Position: Q1 2026 in Review

Highland Capital Management (Tennessee) sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 9,861 shares — an estimated $213K sold.

Highland Capital Management (Tennessee) first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $213K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Highland Capital Management (Tennessee) reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Highland Capital Management (Tennessee) sold 9,861 Avadel Pharmaceuticals shares in Q1 2026, an estimated $213K.
Highland Capital Management (Tennessee) first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Highland Capital Management (Tennessee)'s Avadel Pharmaceuticals position peaked at $213K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q1 2026, filed 13 Apr 2026.